Leveraging our global ecosystem and domain expertise, we support Chinese healthcare and technology entrepreneurs to build bold and meaningful businesses.
Years of investment history
Our team is made up of experienced operators, clinicians and investors who offer significant value-add to our portfolio.
We support aspiring healthcare, technology and consumer businesses, with the aim of setting standards in the market.
Eyebright goes public
Latest from our team and portfolio.
China Ventures Q2 2021 Newsletter
Blueglass bags over $30.9M in new financing
Eight Roads launches new China healthcare fund
Insilico Medicine raises $255m in Series C
See all our teams
Privacy & Legal